Specialized Training for Physicians Interested in BMT and Immunotherapies
This intensive one-year fellowship is designed to prepare physicians for academic careers focused on transplantation and cellular therapy. Our program started in the late 1960s with Nobel prize winner, E. Donnall Thomas, and his team of transplant physicians and clinical staff, who discovered a way to treat advanced leukemia by eradicating malignant white blood cells in the bone marrow using high doses of chemotherapy and radiation, and then replacing them with healthy donor cells. We now have 60 clinical faculty members at Fred Hutch and the University of Washington who specialize in transplantation and cellular therapy and serve as mentors to trainees from around the world.
Program Overview
The BMT and Immunotherapy fellowship is an intense, year-long program to prepare hematology-oncology physicians to become adept in blood and marrow transplantation (BMT) and immunotherapy (IMTX) services.
You will have the opportunity to work with world renowned faculty who are on the cutting edge of novel treatments for malignant and non-malignant diseases. The fellow will rotate through outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up) and IMTX services, and initially function as a primary care provider with increasing levels of patient care responsibility over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available to participate in research projects.
The application system is currently accepting materials for the July 2026 - June 2027 academic years.
Fellowship Co-Directors
Committee Members
Application Instructions
The application system is currently accepting materials for the July 2026 - June 2027 academic years.
- C.V.
- Statement of clinical and research interests
- Personal statement outlining your interests in the fellowship program
- Contact information for at least three professional references (including your hem/onc fellowship director)
- The ideal candidate should have an interest in hematopoietic cell transplantation and/or immunotherapy and should have completed a fellowship in hematology or hematology-oncology.
- All applicants must have a medical doctorate (or foreign equivalent) and be board eligible/certified.
- US graduates must be ABIM board eligible/certified in Hematology and/or Oncology.
- In order to be eligible for sponsorship for an H-1B visa, graduates of foreign medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) and be ECFMG certified.
Questions about the program can be sent to:
Anne Nguyen
Project Manager, Practice Plan
Medical Staff Office